Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 611
Avg Vol 3,514
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 99%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Santen Pharmaceutical Co., Ltd. engages in the research and development, manufacturing, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally. Its product portfolio includes tafluprost/timolol maleate, a prostaglandin F2a derivative and a beta-adrenergic receptor blocker for the treatment of glaucoma and ocular hypertension; ciclosporin, an ophthalmic emulsion for the treatment of vernal keratoconjunctivitis, as well as l...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 81 6 7664 8621
Fax: 81 6 6359 3827
Address:
Grand Front Osaka Tower A, 4-20 Ofuka-cho Kita-ku, Osaka, Japan
Latest News on SNPHY
No data available.